-
公开(公告)号:EP2291375B1
公开(公告)日:2016-01-06
申请号:EP09772064.3
申请日:2009-06-04
申请人: Merck Patent GmbH
发明人: WUCHERER-PLIETKER, Margarita , BRUGE, David , FINSINGER, Dirk , GRAEDLER, Ulrich , DORSCH, Dieter , ESDAR, Christina
IPC分类号: C07D471/04 , A61K31/437 , A61P35/00
CPC分类号: C07D471/04
-
公开(公告)号:EP2807154B1
公开(公告)日:2015-12-23
申请号:EP13701200.1
申请日:2013-01-10
发明人: SCHIEMANN, Kai , STIEBER, Frank , ESDAR, Christina
IPC分类号: C07D241/20 , C07D401/12 , C07D403/12 , C07D403/14 , C07D405/12 , C07D413/12 , C07D417/12 , C07D495/04 , A61K31/4965 , A61K31/497 , A61K31/416 , A61K31/4725 , A61P31/00
CPC分类号: C07D409/12 , A61K31/4965 , A61K31/497 , A61K31/501 , A61K31/506 , A61K31/5377 , A61K31/5415 , C07D241/20 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/12 , C07D413/12 , C07D417/12 , C07D495/04
-
公开(公告)号:EP2748164A1
公开(公告)日:2014-07-02
申请号:EP12740502.5
申请日:2012-07-26
申请人: Merck Patent GmbH
IPC分类号: C07D471/04 , C07D487/04 , A61K31/519 , A61P35/00
CPC分类号: C07D471/04 , C07D473/34 , C07D487/04
摘要: Compounds of formula I, wherein X
1 , X
2 , X
3 , X
4 , X
5 , R
1 , R
2 , R
3 , R
4 , R
5 and R
6 have the meanings indicated in claim 1, are kinase inhibitors and can be used, amongst other things for treating tumors.-
公开(公告)号:EP2606034A1
公开(公告)日:2013-06-26
申请号:EP11743438.1
申请日:2011-07-19
申请人: Merck Patent GmbH
IPC分类号: C07D233/88 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/14 , C07D413/14 , A61K31/505 , A61P35/00
CPC分类号: C07D239/42 , C07D233/88 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/04 , C07D413/12 , C07D413/14 , C07D417/04 , C07D417/12
摘要: The invention relates to compounds of the formula (I), where R
1 , R
2 , and R
3 have the meanings specified in claim 1, are kinase inhibitors and can be used,
inter alia , to treat tumors.-
-
公开(公告)号:EP3402792A1
公开(公告)日:2018-11-21
申请号:EP16812677.9
申请日:2016-12-16
申请人: Merck Patent GmbH
发明人: DORSCH, Dieter , MUZERELLE, Mathilde , BURGDORF, Lars , WUCHERER-PLIETKER, Margarita , CZODROWSKI, Paul , ESDAR, Christina , TSAKLAKIDIS, Christos
IPC分类号: C07D413/14 , C07D403/04 , C07D403/14 , C07D407/14 , C07D417/14 , C07D487/04 , C07D487/10 , C07D497/10 , A61K31/436 , A61K31/4704 , A61K31/5377 , A61K31/5513 , A61P35/00
CPC分类号: C07D403/04 , C07D403/14 , C07D407/14 , C07D413/14 , C07D417/14 , C07D487/04 , C07D487/10 , C07D497/10
摘要: Compounds of the formula (I) in which X1, X2, X3, X4, R1, R2, R3, Q and Y have the meanings indicated in Claim 1, are inhibitors of c-Kit kinase, and can be employed for the treatment of cancer.
-
公开(公告)号:EP2483268B1
公开(公告)日:2016-06-29
申请号:EP10768174.4
申请日:2010-09-06
申请人: Merck Patent GmbH
IPC分类号: C07D413/04 , C07D413/14 , A61K31/4178 , A61K31/44 , A61P35/00 , A61P37/00 , A61P29/00 , A61P11/06 , C07D401/04 , C07D401/14 , C07D409/14 , C07D471/04
CPC分类号: C07D401/14 , A61K31/4178 , A61K31/44 , C07D401/04 , C07D409/14 , C07D471/04
-
8.A QUINOLINE INHIBITOR OF THE MACROPHAGE STIMULATING 1 RECEPTOR MST1 R 有权
标题翻译: CHINOLIN-DERIVAT ALS INHIBITOR VOM MAKROPHAGEN STIMMULIERENDEN 1 REZEPTOR MST1R公开(公告)号:EP3003315A1
公开(公告)日:2016-04-13
申请号:EP14722116.2
申请日:2014-05-07
申请人: Merck Patent GmbH
IPC分类号: A61K31/506 , A61K31/4709 , A61K45/06 , A61P35/00 , A61P31/00 , A61P29/00 , A61P27/06 , A61P25/28 , A61P19/02 , A61P17/06 , A61P15/00 , A61P9/10
CPC分类号: C07D401/14 , A61K31/4709 , A61K31/506 , A61K45/06 , A61K2300/00
摘要: The compound N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)-3-fluorophenyl)-5-ethyl-1-(pyrimidin-5-yl)-1H-pyrazole-4-carboxamide and pharmaceutically usable salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios, is an inhibitor of RON and can be employed, for the treatment of cancer.
摘要翻译: 化合物N-(4 - ((6,7-二甲氧基喹啉-4-基)氧基)-3-氟苯基)-5-乙基-1-(嘧啶-5-基)-1H-吡唑-4-甲酰胺和药学上 可用的盐,互变异构体和立体异构体,包括其所有比例的混合物,均为RON的抑制剂,可用于治疗癌症。
-
公开(公告)号:EP2807154A1
公开(公告)日:2014-12-03
申请号:EP13701200.1
申请日:2013-01-10
发明人: SCHIEMANN, Kai , STIEBER, Frank , ESDAR, Christina
IPC分类号: C07D241/20 , C07D401/12 , C07D403/12 , C07D403/14 , C07D405/12 , C07D413/12 , C07D417/12 , C07D495/04 , A61K31/4965 , A61K31/497 , A61K31/416 , A61K31/4725 , A61P31/00
CPC分类号: C07D409/12 , A61K31/4965 , A61K31/497 , A61K31/501 , A61K31/506 , A61K31/5377 , A61K31/5415 , C07D241/20 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/12 , C07D413/12 , C07D417/12 , C07D495/04
摘要: The invention provides novel substituted azaheterocyclic compounds compounds according to Formula (I), their manufacture and use for the treatment of hyperproliferative diseases such as cancer, inflammatory or degenerative diseases.
-
公开(公告)号:EP3544998A1
公开(公告)日:2019-10-02
申请号:EP17811476.5
申请日:2017-11-21
申请人: Merck Patent GmbH
发明人: IFFLAND, Christel , ESDAR, Christina , ZHAO, Xinyan , AN, Qi , YEH, Johannes , HAO, Gang , TOLEIKIS, Lars , SOOD, Vanita , NANNEMANN, David , LYTLE, Robin , HOCK, Bjoern
-
-
-
-
-
-
-
-
-